Pathogenicity of DNA Variants and Double Mutations in Multiple Endocrine Neoplasia Type 2 and Von Hippel-Lindau Syndrome
Zoran Erlic(University of Zurich), Hartmut P.H. Neumann(University of Freiburg), M. Schott, Michael M. Hoffmann(University Medical Center Freiburg), Kornelia Hasse-Lazar(The Maria Sklodowska-Curie National Research Institute of Oncology), Charis Eng(Cleveland Clinic), Andrzej Januszewicz(Hypertension Institute), Gerlind Franke(University of Freiburg), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Maren Sullivan(General Department of Preventive Medicine), Matti Välimäki(University of Helsinki), Igor Alexander Harsch, Helmut E. Gabbert(Heinrich Heine University Düsseldorf), Mariola Pęczkowska(Institute of Cardiology), Simon F. Preuss(University Hospital Cologne), Dariusz Waligórski(Holy Cross University)
Cited by 76
Related Papers
Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial Paraganglioma
|The American Journal of Human Genetics|2001|1.1k
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
Localization of the gene for Cowden disease to chromosome 10q22–23
|Nature Genetics|1996|670
Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities
|Nature|2012|631
Implementing genomic medicine in the clinic: the future is here
|Genetics in Medicine|2013|581